Company
Pacira BioSciences Inc (NASDAQ:PCRX)’s 12-Month Price Target Currently Stands At 48
In last trading session, Pacira BioSciences Inc (NASDAQ:PCRX) saw 0.47 million shares changing hands with its beta currently measuring 0.55. Company’s recent per share price
